Next-generation biological crop protection powered by nature's own predators
We research, formulate and scale biological technologies — connecting bacteriophage science and beneficial-bacteria research with modern agriculture.
A platform for agricultural biotechnology
At Exacta BioScience we research and develop microbial technologies — from bacteriophages to beneficial bacteria — studying target microorganisms to understand their biology, then formulating and scaling cost-effective solutions for a more conscious, healthy and sustainable agriculture.
Scientific rigour
Every research programme is grounded in mode-of-action understanding, genomics and validated laboratory testing.
Assured scalability
Robust production protocols and downstream processing that take research from the lab to cost-effective supply.
Real-world stability
Formulations designed for stability across the supply chain — stored for more than two years at room temperature.
From discovery to commercial supply
Our end-to-end platform turns microbial biology into reliable technologies.
- 1
Biodiscovery
Identification and isolation of microorganisms from natural sources, selected by mode of action, genomic profile and application potential, with laboratory-scale testing.
- 2
Formulation
Development of stable, cost-effective formulations with 12+ month shelf life, built on plant-biology models.
- 3
Scale-up
Implementation of production processes and downstream processing for purity, co-formulation and a viable commercial supply model.
Why it matters
Environment
Reduces reliance on synthetic chemistry and helps enhance biodiversity.
Farmers
Research aimed at safer, cost-effective technologies that support crop development.
Food safety
Residue-free approaches that support consumer health and market access.
Our research areas
A focused agricultural biotechnology platform.
-
Bacteriophages -
Beneficial bacteria
Backed by partners and institutions
-
Public research funding -
Public research funding -
Partner -
Distributor (Chile) -
Investor
Advancing agriculture, together
Whether you are a researcher, strategic partner or investor, we would like to hear from you.
Talk to our team